Myles Walsh
About Myles Walsh
Myles Walsh serves as the Director of Bio Pharma Business Development at Predicine, where he has worked since 2024. He has extensive experience in the biotech industry, having held various roles at companies such as Insys Therapeutics, Illumina, and Natera.
Current Role at Predicine
Myles Walsh serves as the Director of BioPharma Business Development at Predicine, a role he has held since 2024. In this position, he focuses on advancing business initiatives within the biopharmaceutical sector. His expertise contributes to the strategic direction and growth of Predicine in the competitive landscape of biotechnology.
Previous Experience in BioPharma
Prior to his current role, Myles Walsh worked as the Associate Director of BioPharma Business Development at Predicine from 2022 to 2024. He also held the position of Senior BioPharma Business Development Manager for Oncology at Natera from 2019 to 2022. His experience includes significant roles at Insys Therapeutics, where he served as a Senior Specialty Sales Professional from 2012 to 2017 and as a District Sales Trainer from 2014 to 2016.
Customer Support Experience at Illumina
Myles Walsh began his career in the biotechnology field as a Customer Support Specialist at Illumina from 2010 to 2012. This role provided him with foundational experience in customer relations and support within a leading genomics company, contributing to his understanding of client needs in the biopharmaceutical industry.
Educational Background in Biology and Biotechnology
Myles Walsh earned a Bachelor of Science degree in Biology & Biotechnology and Spanish from Worcester Polytechnic Institute, where he studied from 2006 to 2010. This educational background laid the groundwork for his career in the life sciences and biopharmaceutical sectors.
Volunteer Experience at UMass Medical School
Myles Walsh volunteered at UMass Medical School from 2009 to 2010. This experience allowed him to engage with the medical community and gain insights into the healthcare environment, further enhancing his knowledge and skills in the life sciences.